Home / Biotechnology / Sepsis Diagnostics Market By Product (Blood Culture Media, Assay Kits And Reagents, Instruments), By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Sepsis Diagnostics Market By Product (Blood Culture Media, Assay Kits And Reagents, Instruments), By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Published: Dec 2017 | Report Code: 58913-12-17

Sepsis patients present with several symptoms ranging from tremors, fever, to severe confusion. However, the most critical indication of sepsis is sudden and significant drop in blood pressure, leading to incidence of septic shock and consequent organ failure. Sepsis is one of the prime causes of in-hospital mortality and also ranks among the most cost-intensive conditions being treated in hospitals worldwide.

Despite its humongous prevalence, sepsis treatment remains an object of speculation in several ways. Sepsis is termed as a syndrome and not a single disease, thus exhibiting as a collection of several causes and effects on patients. As the clinical understanding sepsis is advancing, the definition and diagnosis methods of sepsis are also correspondingly changing. Furthermore, being an expensive condition to treat, healthcare providers worldwide are emphasizing on earliest detection of sepsis and establishment of a standard guideline for intervention.

The scope of this report on sepsis diagnostics market offers detailed analysis of the market based on diagnosis products, technologies and geographical segmentation. Based on product types, the global sepsis diagnostics market is studied for blood culture media, assay kits and reagents and instruments. Molecular diagnostics, microbiology, immunoassays, and flow cytometry are the technologies that are employed for efficient diagnosis of sepsis. Each of such mentioned segment is studied in terms of the latest prevalent market trends along with their market size and forecast for the period 2015 to 2025. In addition, the CAGRs of these segments for the forecast period 2017-2025 are also included in this study.

Based on geographical demarcation of the globe, the sepsis diagnostics market is studied for North America (comprising United States and Canada), Europe (studied for United Kingdom, Germany and Rest of Europe), Asia Pacific (cumulative to China, Japan and Rest of Asia Pacific), Latin America (including Brazil, Mexico and Rest of Latin America), and Middle East and Africa (GCC and Rest of Europe). Market size and forecast is also presented for each regional and country-level market for the considered analysis period.

Sepsis Diagnostics Market

This report also analyzes the global market with the perspective of currently prevalent drivers and restraining factors. Future opportunities to be harnessed are also discussed in this study. The report also studied the competitive landscape of the major market players for the year 2016. Attractive investment proposition is also presented in this study to suggest the most prominent regional market eligible for proliferation, focus and corresponding investment. This report concludes with profiles of major players enjoying prominent position in the global sepsis diagnostics market.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Sepsis Diagnostics Market Portraiture
2.1.1. Global Sepsis Diagnostics Market, by Product, 2016
2.1.2. Global Sepsis Diagnostics Market, by Technology, 2016
2.1.3. Global Sepsis Diagnostics Market, by Geography, 2016

Chapter 3. Sepsis Diagnostics: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition, by Product, 2016
4.3. Blood Culture Media
4.4. Assay Kits and Reagents
4.5. Instruments

Chapter 5. Global Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition, by Technology, 2016
5.3. Microbiology
5.4. Molecular Diagnostics
5.5. Immunoassays
5.6. Flow Cytometry

Chapter 6. Global Sepsis Diagnostics Market, by Geography, 2015 – 2025
6.1. Overview
6.2. North America Sepsis Diagnostics Market Analysis, 2015 – 2025
6.2.1. North America Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
6.2.2. North America Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
6.2.3. North America Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Sepsis Diagnostics Market Analysis, 2015 – 2025
6.3.1. Europe Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
6.3.2. Europe Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
6.3.3. Europe Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Sepsis Diagnostics Market Analysis , 2015 – 2025
6.4.1. Asia Pacific Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of APAC
6.5. Latin America Sepsis Diagnostics Market Analysis , 2015 – 2025
6.5.1. Latin America Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Sepsis Diagnostics Market Analysis, 2015 – 2025
6.6.1. MEA Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
6.6.2. MEA Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
6.6.3. MEA Sepsis Diagnostics Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Becton, Dickinson and Company
7.3. Biomerieux, Inc.
7.4. Bruker Corporation
7.5. Cepheid, Inc.
7.6. Immunexpress, Inc.
7.7. Nanosphere, Inc. (A Luminex Company)
7.8. Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
7.9. T2 Biosystems, Inc.
7.10. Thermo Fisher Scientific, Inc.

List of Tables :

TABLE 1 Global Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 2 Global Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 3 North America Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 4 North America Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 5 North America Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Asia Pacific Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Latin America Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 13 Latin America Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Middle East and Africa Sepsis Diagnostics Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 16 Middle East and Africa Sepsis Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East and Africa Sepsis Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 18 Abbott Laboratories Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Becton, Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Biomerieux, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Bruker Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Cepheid, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Immunexpress, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Nanosphere, Inc. (A Luminex Company): Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.) : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 T2 Biosystems, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

List of Figures :

FIG. 1 Sepsis Diagnostics: Market Segmentation
FIG. 2 Global Sepsis Diagnostics Market, by Product, 2016 (US$ Mn)
FIG. 3 Global Sepsis Diagnostics Market, by Technology, 2016 (US$ Mn)
FIG. 4 Global Sepsis Diagnostics Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Blood Culture Media Market in Sepsis Diagnostics, 2015 – 2025 (US$ Mn)
FIG. 8 Global Assay Kits and Reagents Market in Sepsis Diagnostics, 2015 – 2025 (US$ Mn)
FIG. 9 Global Instruments Market in Sepsis Diagnostics, 2015 – 2025 (US$ Mn)
FIG. 10 Global Microbiology Based Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Molecular Diagnostics Microbiology Based Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Immunoassay Microbiology Based Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Flow Cytometry Microbiology Based Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 14 U.S. Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 15 Canada Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 16 U.K. Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 17 Germany Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 18 Rest of Europe Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 20 China Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 21 Rest of Asia Pacific Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 22 Brazil Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 23 Mexico Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 24 Rest of Latin America Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 25 GCC Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 26 Rest of Middle East and Africa Sepsis Diagnostics Market, 2015 – 2025 (US$ Mn)

Based on product types, the global sepsis diagnostics market is segmented as follows:  

  • Blood Culture Media
  • Assay Kits and Reagents
  • Instruments

Sepsis is one the most common causes of the death in hospitals. It is projected that sepsis diagnostics market will show prominent market growth during the forecast period due to significant growth in the number of sepsis patients emerging from rise in the number of surgeries, hospital-acquired infections, and technological advancement in sepsis management. Early detection is eminently needed for the improved outcome of treatment to patients affected with sepsis. It is studied that in the recent years, blood culture media has been the largest revenue contributing segment because it remains the gold standard detection method in microbiological diagnosis of sepsis due to its sensitivity and specificity. A number of advancements are made in blood culture media, such as development in enriched growth media, software for faster detection, etc. Despite these technological advancements, blood culture remains a time consuming method. Moreover, risk of false negative results due to the inhibitory effects of fastidious pathogens and antibiotics also limits the use of blood culture media.

It is anticipated that assay kits will show lucrative market growth during the forecast period due to rising adoption of assay kits, faster detection method, and growing approval for assay kits. Although there are number of manufacturers present in market, the assay kits and reagent market is currently dominated by, Thermo Fisher Scientific, Roche Diagnostics, T2 Biosystems, Bruker Corporation etc.

 Sepsis Diagnostics Market

Based on technology type, the global sepsis diagnostics market is segmented as follows:  

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry

Despite the advancement in healthcare system, mortality related to sepsis remains high; accurate diagnosis is significant for correct identification of sepsis causing pathogens. At present, molecular diagnostic techniques are emerging and it is expected to show the highest market growth over the forecast period, as it is a rapid and accurate process over the conventional method. Previously, microbiology detection technique is widely accepted detection technique but due to more time consumption and increase in chance of false negative result demand for molecular diagnostics increase in market.

Molecular diagnostics techniques allows rapid detection of pathogen involved in sepsis. Furthermore, advancement in nucleic acid extraction and amplification would further assist the growth of molecular diagnostics segment globally. Technological advancements in molecular diagnostics, higher sensitivity, specificity, ability to detect fastidious or slow-growing organisms, reduced inhibitory effect of antibiotic and lesser turnaround time would drive the growth of molecular diagnostics market during the forecast period. On the other hand, some factors such as, risk of false positive results due to presence of contamination, lack of reference standard for laboratory standardization process and unfeasibility for recovery of live bacterial strain for additional diagnostic tests may negatively impact the growth of molecular diagnostics segment.

 Sepsis Diagnostics Market

For the purpose of this study, the global sepsis diagnostics market is categorized into:

  • North America
    • United States
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Sepsis Diagnostics Market

According to Centers for Disease Control and Prevention (CDC), one in every three patients who die in hospital have sepsis. As reported in JAMA study, 1.7 million hospitalizations and 270,000 deaths in the United States alone were accounted to sepsis. United States is the largest market for sepsis diagnostics. Dominance of United States and therefore North America market is due to phenomenal incidence of sepsis in hospitalization, significant costs and eminent high risk of mortality, thus prompting the need for early diagnosis. On the other hand, countries such as India, China, Philippines and Australia will collectively render rapid growth to the Asia Pacific sepsis diagnostics market. Rapid growth of healthcare system, growing ease in availability of novel diagnostic and screening methods and perpetual rise in incidence of sepsis.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients